Table 5.
Associations of clinical characteristics and depression among an adult patient’s living with HIV/AIDs
| Characteristics | Depression | OR (95%CI) | p-value | AOR (95% CI) | p-value | |
|---|---|---|---|---|---|---|
| Yes (%) | No (%) | |||||
| CD4 level (cell/dL) | ||||||
| <200 | 11(23.9%) | 35(76.1%) | 0.037 (0.013–0.105) | < 0.001* | ||
| 200–1000 | 41(18.7%) | 178(81.3%) | 0.027 (0.012–0.064) | < 0.001* | ||
| >1000 | 59(89.4) | 7(10.6) | 1 | |||
| Perceived stigma | ||||||
| Stigmatized | 66(76.7) | 20(23.3) | 14.66 (8.08–26.61) | < 0.001* | ||
| Non-stigmatized | 45(18.4) | 200(81.6) | 1.00 | |||
| Social support | ||||||
| Poor | 65(78.3) | 18(21.7) | 15.85(8.59–29.25) | < 0.001* | 3.415 (1.465–7.960) | 0.004* |
| Moderate- Strong | 46(18.5) | 202(81.5) | 1.00 | 1.00 | ||
| Years HIV Infected (years) | ||||||
| < 1 | 16(34.0) | 31(66.0) | 1.00 | |||
| 1–3 | 77(33.2) | 155(66.8) | 0.96(0.496–1.867) | 0.910 | ||
| >3 | 18(34.6) | 34(65.4) | 1.02(0.447–2.354) | 0.952 | ||
| Having opportunistic infection currently | ||||||
| Yes | 36(92.3) | 3(7.7) | 34.72 (10.3–116.0) | < 0.001* | ||
| No | 75(25.7) | 217(74.3) | 1.00 | |||
| HIV stage | ||||||
| Stage I/ II | 67(23.8) | 214(76.2) | 1.00 | |||
| Stage III/IV | 44(88.0) | 6(12.0) | 23.42(9.56–57.38) | < 0.001* | ||
| Treatment type | ||||||
| First-line | 71(24.6) | 218(75.4) | 1.00 | |||
| s-line | 40(95.2) | 2(4.8) | 61.40(14.47–260.50) | < 0.001* | ||
| Treatment adherence | ||||||
| Good | 45(17.4) | 213(82.6) | 1.00 | 1.00 | ||
| Moderate- Poor | 66(90.4) | 7(9.6) | 44.62(19.21-103.67.55) | < 0.001* | 14.307(5.361–38.182) | < 0.001* |
| HIV status disclosure | ||||||
| Yes | 97(31.6) | 210(68.4) | 1.00 | |||
| No | 14(58.3) | 10(41.7) | 3.03 (1.30–7.06) | 0.010* | ||
| Substance abuse | ||||||
| Yes | 54(53.5) | 47(46.5) | 3.48 (2.13–5.70) | < 0.001* | 3.422 (1.727–6.781) | 0.001* |
| No | 57(24.8) | 173(75.2) | 1.00 | 1.00 | ||
*Significant level at α = 0.05